[1]
Sharmeen, O., Rashid, M.H., Rouf, M.A. and Islam, A. 2018. Subcutaneous Anti-D versus intravenous methylprednisolone for the treatment of immune thrombocytopenic purpura. International Journal of Contemporary Pediatrics. 5, 5 (Aug. 2018), 1719–1723. DOI:https://doi.org/10.18203/2349-3291.ijcp20183505.